Privia Health Q3 2026: Growth, Acquisitions, and a Montana Exit
Privia Health Group, Inc. (Nasdaq: PRVA) reported a robust third quarter and year-to-date results for the nine months ended September 30, 2026. The quarterly revenue came in at $657.0 million, up from $580.4 million a year earlier, delivering a 13.2% year-over-year rise. Even if you don’t read the charts the way a Wall Street economist does, the message is clear: the company is expanding its footprint in the value-based care (VBC) ecosystem, while improving profitability. Investors will watch how this translates into EPS and where the EPS consensus lines up against the company’s stated revenue forecast and potential earnings surprise on the next earnings call.
Key numbers in plain English
- Net income (YTD): $25.6 million, up 85.9% from YTD 2025.
- Adjusted EBITDA (YTD): $114.7 million, up 21.9% from YTD 2025.
- Three months ended September 30, 2026: Revenue of $657.0 million (vs. $580.4 million in 2025), a 13.2% uplift.
Guidance and strategic moves
Privia raised its Full-Year 2026 guidance to above the high end for all key financial metrics, signaling confidence in ongoing operating leverage as the VBC mix deepens. The company attributes this momentum to a strengthened footprint in value-based care delivery and underlines a strategic push to scale through managed services and bundled care arrangements.
In a move that reads like a calculated bet on MSSP-enabled growth, Privia disclosed the acquisition of American Choice Healthcare MSSP—a purchase designed to deepen MSSP capabilities and expand its managed services capacity. The strategic rationale, in plain terms: more revenue from contracts that flow through risk-adjusted models, less exposure to fee-for-service volatility.
Portfolio moves: exits and expansion
Privia also announced the exit of the Montana Partnership, effective January 2027. Exiting a market is rarely delicious, but the calculus is straightforward: redeploy capital toward higher-growth opportunities and mitigate a geographic drag on margins. The Montana exit, combined with the MSSP acquisition, suggests the company is balancing breadth with depth—keeping a viable footprint while betting on higher-margin, higher-visibility earnings streams.
What this implies for Privia and sector peers
Privia’s Q3 results reinforce a familiar theme in healthcare services: growth accrues not just from serving more patients, but from shifting the mix toward value-based care models that align incentives with improved outcomes. The topline strength, coupled with margin expansion via higher-quality revenue streams, positions Privia as a potential yardstick for peers pursuing MSSP-enabled growth and selective geographic refinement.
For investors, the next test is EPS realization and how the company’s reported earnings stack up against consensus estimates. The narrative so far hints at a favorable trajectory, but the true test will come with quarterly cadence and the ability to sustain higher revenue forecast quality, even as the company navigates portfolio changes and integration of the new MSSP asset.
Takeaway: disciplined growth with a side of portfolio optimization
Privia’s Q3 2026 release reads as a deliberate expansion play: grow the revenue engine, improve profitability, and prune underperforming parts of the portfolio. The implied earnings surprise risk remains manageable if the company can translate added MSSP capabilities into steady gross margins and disciplined operating expenses. In the broader sector, Privia’s path—accelerating in value-based care while pruning legacy exposure—may become a blueprint for other players weighing similar strategic bets.
In the end, Privia’s mix of robust quarter, stronger YTD profitability, and strategic portfolio moves could reshape earnings expectations across the VBC landscape. If the company sustains momentum, expect peers to reassess MSSP bets, geographic concentration, and the pace at which they can convert contracts into durable EBITDA, not just revenue fireworks.